# Assessing the genetic profile of cytochrome P450 and glutathione S-transferases of patients diagnosed with acute myeloid leukemia

**Authors:** Gilmar de Andrade França, Luciana Nardinelli, Ricardo Rodrigues Giorgi, Thiago Pagliarini, Otávio César Carvalho Guimarães Baiocchi, Elvira Deolinda Rodrigues Pereira Velloso, Wellington Fernandes da Silva Jr, Eduardo Magalhães Rego, Israel Bendit

PMC · DOI: 10.1016/j.htct.2025.103759 · Hematology, Transfusion and Cell Therapy · 2025-05-07

## TL;DR

This study found that genetic variations in CYP450 and GST genes are linked to slower blood cell recovery in acute myeloid leukemia patients.

## Contribution

The novel contribution is identifying a correlation between CYP450/GST gene polymorphisms and delayed neutrophil recovery in AML patients.

## Key findings

- 76 polymorphisms (38 deletions and 38 duplications) were identified in CYP450 and GST genes.
- Patients with polymorphisms had significantly longer neutrophil recovery times (p-value = 0.0056).
- CYP450 and GST gene polymorphisms may affect recovery after AML treatment.

## Abstract

This study aimed to determine the frequency of genetic alterations as deletions and duplications in cytochrome P450 (CYP450) and glutathione S-transferases (GST) genes, as well as to investigate whether there is a relationship between these alterations and neutrophilic hematologic recovery in adult patients diagnosed with acute myeloid leukemia.

DNA samples from 70 patients diagnosed with acute myeloid leukemia were evaluated using the Multiplex Ligation-dependent Probe Amplification technique. The presence or absence of polymorphisms was compared regarding the time to neutrophilic recovery (neutrophil count ≥1.0 × 109/L) using Kaplan-Meier curves, with the comparison between the curves being performed using the non-parametric log-rank test.

The median age of the participants was 57 years, with a higher proportion of females (57.2%) and white individuals (61.4%)’. A total of 76 polymorphisms (CYP450 + GST) were identified, comprising 38 deletions and 38 duplications. Kaplan-Meier curves revealed that the neutrophilic recovery time was longer for the group with polymorphisms (p-value = 0.0056).

The study demonstrated that CYP450 and GST genes are polymorphic, and these polymorphisms may lead to longer neutrophilic recovery after induction treatment of acute myeloid leukemia remission.

## Linked entities

- **Genes:** CYP71B9 (cytochrome P450, family 71, subfamily B, polypeptide 9) [NCBI Gene 814788], LOC107927610 (alkane hydroxylase MAH1-like) [NCBI Gene 107927610], SLCO6A1 (solute carrier organic anion transporter family member 6A1) [NCBI Gene 133482]
- **Diseases:** acute myeloid leukemia (MONDO:0015667)

## Full-text entities

- **Genes:** GSTK1 (glutathione S-transferase kappa 1) [NCBI Gene 373156] {aka GST, GST 13-13, GST13, GST13-13, GSTK1-1, hGSTK1}, CYP4F3 (cytochrome P450 family 4 subfamily F member 3) [NCBI Gene 4051] {aka CPF3, CYP4F, CYPIVF3, LTB4H}
- **Diseases:** acute myeloid leukemia (MESH:D015470)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12131003/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12131003/full.md

## References

28 references — full list in the complete paper: https://tomesphere.com/paper/PMC12131003/full.md

---
Source: https://tomesphere.com/paper/PMC12131003